Vestibular schwannomas (VS) are increasingly being managed with LINAC-based stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (fSRT). There is a paucity of long-term outcomes especially in relation to post-treatment volumetric tumour and pseudoprogression data.
✦ The floor
Discussion
Signed responses from readers of the wire.
This retrospective comparison may inform radiation oncology planning for vestibular schwannoma, but audiologists should await prospective data before changing referral or counseling practices.
Understanding which radiation approach better preserves hearing and controls tumor growth could directly shape multidisciplinary management guidelines for vestibular schwannoma.
- 01Retrospective design comparing single-dose LINAC radiosurgery vs. fractionated stereotactic radiotherapy for vestibular schwannoma.
- 02Long-term outcomes assessed — likely including tumor control, hearing preservation, and cranial nerve function.
- 03Vestibular schwannomas are a key differential in audiology practice requiring specialist referral.
- 04Findings could influence referral pathways and patient counseling about radiation options.
- 05Retrospective methodology limits causal inference; prospective trials are needed.
Long-term outcomes differ between single-dose LINAC radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
studypartially supported- PMID
- 43059592
- DOI
- 10.1080/02688697.2026.2764164.
- Journal
- British Journal of Neurosurgery
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with vestibular schwannoma treated with stereotactic radiation
- Intervention
- Single-dose LINAC stereotactic radiosurgery
- Comparator
- Fractionated stereotactic radiotherapy
Primary outcomes
Tumor control rate; Hearing preservation; Cranial nerve outcomes